期刊文献+

基于一致性评价导向的国家基本药物口服制剂信息集萃 被引量:1

Information Compilation on Oral Preparations in National Essential Drugs List for Therapeutic Equivalence Evaluation of Generic Drugs
原文传递
导出
摘要 初步整理了国家基本药物口服制剂信息,包括药物疾病分类、中英文通用名、剂型、规格、国产批文数量、原研公司、原研商品名、原研剂型、原研规格、BCS分类等,旨在为仿制药一致性评价工作提供借鉴。 To provide references for the therapeutic equivalence evaluation of generic drugs, information on oral preparations in National Essential Drugs List was compiled, including therapeutic category, generic names in both Chinese and English, dosage form, strength, the number of CFDA approval, BCS classification, as well as applicant, proprietary name, dosage form and strength of reference listed drug(RLD).
出处 《药学进展》 CAS 2016年第3期213-229,共17页 Progress in Pharmaceutical Sciences
关键词 仿制药一致性评价 国家基本药物 口服制剂 参比制剂 生物药剂学分类 therapeutic equivalence evaluation of generic drug national essential drugs oral preparation reference preparation BCS classification
  • 相关文献

参考文献7

  • 1Pediatric Formulations Plalibml. lntra-Agency Agreement Between the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) and the U.S. Food and Drug Administration (FDA) Oral Formulations Platform-Report I [R/OL]. 2012. [2016- 02-01]. https://bpca.nichd.nih.gov/collaborativeefforts/initiatives/ Documents/Fonmilations_Plat lbml_Report l.pdf.
  • 2World Health Organization. Proposal to waive in vivo bioequivalence requirements tbr WHO Model List of Essential Medicines immediate- release, solid oral dosage forms: WHO Technical Report Series Annex 8 [R]. Geneva: WHO, 2006.
  • 3Prabhu N B, Marathe A S, Jain S K, et al. Comparison of dissolution profiles for sustained release resinates of BCS Class I Drugs Using USP Apparatus 2 and 4: A Technical Note [J]. AAPS Pharm & Tech, 2008, 9 (3): 769-773.
  • 4Elgart A, Cherniakov 1, Aldouby Y, et al. Improved oral bioavailability of BCS class 2 compounds by selfnano-emulsifying drug delivery systems (SNEDDS): the underlying mechanisms tbr amiodarone and talinolol[J]. Pharm Res, 2013, 30(12): 3029-3044.
  • 5Quan P, Xia D, Piao H, et al.Nitrendipinenanocrystals: its preparation, characterization, and in vitro-in vivo evaluation[J]. AAPS Pharm Sci Tech, 2011, 12(4): 1136-1143.
  • 6Zaki N M, Artursson P, Bergstrom C A S. A modified physiological BCS tbr prediction of intestinal absorption in drug discovery [J]. Mol Pharm, 2010, 7 (5): 1478-1487.
  • 7Mu H, Holm R, Mtillertz A. Lipid-based formulations for oral administration of poorly water-soluble drugs [J]. Int J Pharm, 2013, 453 (1): 215-224.

同被引文献5

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部